A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$38.25
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap (2006)
Board on Health Sciences Policy (HSP)
Space Studies Board (SSB)
Aeronautics and Space Engineering Board (ASEB)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Appendix E Integration of Data-Based Evidence and Expert Opinion in Decision Making." A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press, 2006.

Please select a format:

Page
123


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap

and model-averaging techniques or informally by choosing plausible values of model and prior distribution parameters (Spiegelhalter et al., 1994).

REFERENCES

Bellman RE. 1957. Dynamic Programming. Princeton, NJ: Princeton University Press.

Berger JO. 1985. Statistical Decision Theory and Bayesian Analysis, 2nd Ed. New York: Springer-Verlag.

Chaloner K, Rhame FS. 2001. Quantifying and documenting prior beliefs in clinical trials. Statistics in Medicine 20: 581–600.

Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). 1996. Cost-Effectiveness in Health and Medicine. Oxford, UK: Oxford University Press.

Lindley DV. 1985. Making Decisions, 2nd Ed. New York: Wiley.

Matchar DB, Samsa GP. 1999. Using outcome data to identify best medical practice: the role of policy models. Hepatology 29 (6 Suppl): 36S–39S.

Matchar DB, Samsa GP, Mathews JR, Aneukiewicz M, Parmigiani G, Hasselblad V, Wolf PA, D’Agostino RB, Lipscomb J. 1997. The Stroke Prevention Policy Model (SPPM): linking evidence and clinical decisions. Ann. Int. Med. 127: 704–711.

Parmar MKB, Griffiths GO, Spiegelhalter DJ, Souhami RL, Altman DG, van der Scheuren E, CHART steering committee. 2001. Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet 358(9279): 375–381.

Parmar MKB, Spiegelhalter DJ, Freedman LS. 1994. The CHART trials: Bayesian design and monitoring in practice. Statistics in Medicine 13: 1297–1312.

Pliskin JS, Shepard D, Weinstein MC. 1980. Utility functions for life years and health status: theory, assessment, and application. Operations Research 28: 206–224.

Spiegelhalter DJ, Freedman LS, Parmar MKB. 1994. Bayesian approaches to randomised trials. J. R. Stat. Soc. A 157: 357–387.

Tan SB, Chung YF, Tai BC, Cheung YB, Machin D. 2003. Elicitation of prior distributions for a phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma. Control. Clin.Trials 24(2): 110–121.

Vennix JAM, Anderson DF, Richardson GP, Rohrbaugh J. 1994. Model building for group decision support: issues and alternatives in knowledge elicitation. In Morecroft J, Sterman J. (eds.) Modeling for Learning Organizations. Portland, OR: Productivity Press.